Amino acid replacement: Q401term.
C11618068T
Q401term | Met-PA; Q401term | Met-PB
Q401term
Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.
Homozygotes show increased resistance to methoprene compared to controls.
Homozygous females have a reduced rate of oviposition compared to controls.
16% of mutant flies have a small number of defective ommatidia in the posterior quarter of the eye.
Flies carrying Rst(1)JH2 have a competitive disadvantage compared to wild-type flies.
Rst(1)JH1 mutants are 6 times more resistant than wild-type to S31183 (2-1-methyl-2-(4-phenoxyphenoxy)-ethoxy-pyridine), a juvenile hormone mimic, in a white puparial assay and about 20 times more resistant than wild-type to S31183 in a larval feeding assay.
Homozygotes are resistant to methoprene, although less strong than Rst(1)JH1. Also resistant to methoprene induced morphogenetic abnormalities and tumours. Heterozygous males are susceptible to methoprene. Rst(1)JH1/Rst(1)JH2 transheterozygotes are more resistant to methoprene than Rst(1)JH2 homozygotes.
The fitness component(s) responsible for the competitive disadvantage of flies carrying mutant alleles of Rst(1)JH have been analysed in Rst(1)JH1, Rst(1)JH2, Rst(1)JH3, Rst(1)JHD29 and Rst(1)JHN6 flies. Small but significant differences were found between the pooled Rst(1)JH alleles and wild-type for pupal developmental time, pupal mortality, and early adult fecundity. These differences results in a large competitive disadvantage.